FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to medicine, chemical and pharmaceutical industry, namely to compounds having anticancer activity, and concerns obtaining an injectable dosage form of actinomycin D. Described is the pharmaceutical formulation for injections in the form of a solution which contains actinomycin D dissolved in 0.2 % sodium hydroxide or a phosphate buffer with pH 6.5-7.5 as an active ingredient and carbohydratethe as an auxiliary substance, selected from mannitol and dextrose, and water for injections in quantities specified in the patent claim. Invention extends the range of liquid forms of actinomycin D-based preparations for injections.
EFFECT: disclosed formulation is stable and is prepared without adding stabilisers such as metabisulphite, sodium bisulphite, Trilon B.
3 cl, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHARAMCEUTICAL COMPOSITION FOR TREATMENT OF ONCOLOGICAL DISEASES | 2012 |
|
RU2484814C1 |
HIGH-STABLE PHARMACEUTICAL FORMULATION OF LYOPHILISATE OF 3-OXYPYRIDINE AND METHYLPYRIDINE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2012 |
|
RU2504376C1 |
PHARMACEUTICAL COMPOSITION FOR ONCOLOGICAL DISEASES | 2011 |
|
RU2463053C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT GROWTHS OF PROSTATE GLANDS | 2015 |
|
RU2589266C1 |
PHARMACEUTICAL FORMULATION FOR TREATING DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION | 2012 |
|
RU2504375C1 |
METHOD FOR PREVENTION OR TREATMENT OF CORONAVIRUS AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS | 2022 |
|
RU2794315C1 |
LYOPHILISATE BASED ON PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS FOR PREPARING A RADIOPHARMACEUTICAL COMPOSITION IN FORM OF SOLUTION FOR INJECTIONS FOR TREATING PROSTATE CANCER, RADIOPHARMACEUTICAL COMPOSITION BASED ON IT FOR TREATING PROSTATE CANCER AND METHOD FOR PREPARING RADIOPHARMACEUTICAL COMPOSITION | 2023 |
|
RU2817970C1 |
INJECTION FORM OF PHARMACEUTICAL COMPOSITION (VERSIONS) FOR PREVENTING AND TREATING NEUROPATHIES AND METHOD FOR PREPARING IT | 2010 |
|
RU2448706C2 |
PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY IN INJECTION FORM (VERSIONS) | 2013 |
|
RU2563211C2 |
INJECTION DALARGIN SOLUTION | 2003 |
|
RU2241488C1 |
Authors
Dates
2016-06-20—Published
2014-01-14—Filed